Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

206.98 +1.63 (+0.79%)
Streaming Delayed Price Updated: 12:06 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency
On February 11, 2026, the clinical laboratory landscape is recalibrating following a whirlwind 48 hours of financial and regulatory news. Quest Diagnostics (NYSE: DGX), the nation’s leading provider of... 
Via Finterra
Topics Artificial Intelligence
News headline image
DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 7.1% year on year to $2.81 billion. The company’s... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Is Quest (DGX) Stock Soaring Today
Shares of healthcare diagnostics company Quest Diagnostics (NYSE:DGX) jumped 6.8% in the afternoon session after the company reported strong fourth-quarter financial results and offered an upbeat... 
Via StockStory
Quest Diagnostics Inc (NYSE:DGX) Beats Q4 Estimates, Announces Dividend Hike and $1B Buyback ↗
Via Chartmill
Quest Diagnostics Inc (NYSE:DGX) Offers a Reliable Dividend with Strong Growth and Profitability ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike ↗
Quest Diagnostics (NYSE: DGX) reported Q4 earnings of $2.42 per share, beating expectations. Sales were $2.81B, up 7.1% YoY. 
Via Benzinga
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗
Via Chartmill
Stay informed with the top movers within the S&P500 index on Tuesday. ↗
Via Chartmill
News headline image
Quest Diagnostics (DGX) Earnings Call Transcript ↗
Quest Diagnostics (DGX) Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Quest Diagnostics Inc. (NYSE:DGX): A Prime Pick for Steady, Growing Dividends ↗
Via Chartmill
News headline image
Quest’s (NYSE:DGX) Q4 CY2025: Beats On Revenue
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) announced better-than-expected revenue in Q4 CY2025, with sales up 7.1% year on year to $2.81 billion. The company’s full-year revenue... 
Via StockStory
News headline image
Quest (DGX) Q4 Earnings: What To Expect
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be announcing earnings results this Tuesday morning. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Should You Buy Guardant Health Before Feb. 19? ↗
This genomics stock appears to be at an inflection point. 
Via The Motley Fool
Topics Earnings
News headline image
3 Unpopular Stocks with Questionable Fundamentals
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
Via StockStory
News headline image
3 Mid-Cap Stocks We Find Risky
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
News headline image
3 Reasons to Sell DGX and 1 Stock to Buy Instead
Quest trades at $179.96 and has moved in lockstep with the market. Its shares have returned 6.9% over the last six months while the S&P 500 has gained 11.3%. 
Via StockStory
Topics Stocks
News headline image
GRAIL Surges as Canaccord Genuity Sets Ambitious $105 Price Target Following Robust 2025 Growth
In a resounding vote of confidence for the future of multi-cancer early detection (MCED), Canaccord Genuity reiterated its "Buy" rating for GRAIL (Nasdaq: GRAL) on Tuesday, January 13, 2026, setting an... 
Via MarketMinute
News headline image
Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q3, starting... 
Via StockStory
News headline image
Quest Diagnostics Inc. (NYSE:DGX) Stands Out as a Dependable Dividend Stock ↗
Quest Diagnostics (DGX) offers a reliable dividend with a strong yield, backed by consistent growth, solid profitability, and a sustainable payout ratio for income investors. 
Via Chartmill
News headline image
1 S&P 500 Stock to Target This Week and 2 We Brush Off
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
News headline image
Quest (DGX) Q3 2025 Earnings Call Transcript ↗
Quest (DGX) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Quest Diagnostics Inc (NYSE:DGX) Presents a Strong Case for Dividend Investors ↗
Quest Diagnostics (DGX) offers a strong dividend profile with a 1.71% yield, steady growth, and a sustainable payout, backed by solid profitability and financial health. 
Via Chartmill
News headline image
Pfizer, UnitedHealth, Viatris, Addus HomeCare, and Quest Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. 
Via StockStory
Topics Economy
News headline image
Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing ↗
Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories. 
Via Benzinga
News headline image
Quest Diagnostics Solidifies Shareholder Value with $0.80 Quarterly Dividend
Securing Shareholder Returns in a Dynamic Healthcare Landscape Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, has declared a quarterly cash dividend of $0.80 per... 
Via MarketMinute
News headline image
Quest Diagnostics (NYSE: DGX) Bolsters Shareholder Confidence with Latest Dividend Declaration
Secaucus, NJ – November 11, 2025 – Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, has declared a quarterly cash dividend of $0.80 per share, reaffirming its... 
Via MarketMinute
News headline image
Economic Crossroads: How Key Indicators Are Steering the Stock Market Through Moderation and Policy Shifts
The financial markets are currently navigating a complex and often contradictory economic landscape, heavily influenced by a suite of critical indicators such as jobs data and the Purchasing Managers'... 
Via MarketMinute
Topics Artificial Intelligence Economy Immigration
News headline image
3 Low-Volatility Stocks We Think Twice About
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
3 Healthcare Stocks We Steer Clear Of
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This... 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.